Quest Other Stockholder Equity vs Total Current Liabilities Analysis
DGX Stock | USD 141.97 2.64 1.89% |
Quest Diagnostics financial indicator trend analysis is much more than just breaking down Quest Diagnostics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Quest Diagnostics is a good investment. Please check the relationship between Quest Diagnostics Other Stockholder Equity and its Total Current Liabilities accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Quest Diagnostics Incorporated. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.
Other Stockholder Equity vs Total Current Liabilities
Other Stockholder Equity vs Total Current Liabilities Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Quest Diagnostics Other Stockholder Equity account and Total Current Liabilities. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between Quest Diagnostics' Other Stockholder Equity and Total Current Liabilities is -0.66. Overlapping area represents the amount of variation of Other Stockholder Equity that can explain the historical movement of Total Current Liabilities in the same time period over historical financial statements of Quest Diagnostics Incorporated, assuming nothing else is changed. The correlation between historical values of Quest Diagnostics' Other Stockholder Equity and Total Current Liabilities is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Stockholder Equity of Quest Diagnostics Incorporated are associated (or correlated) with its Total Current Liabilities. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Liabilities has no effect on the direction of Other Stockholder Equity i.e., Quest Diagnostics' Other Stockholder Equity and Total Current Liabilities go up and down completely randomly.
Correlation Coefficient | -0.66 |
Relationship Direction | Negative |
Relationship Strength | Weak |
Other Stockholder Equity
Total Current Liabilities
Total Current Liabilities is an item on Quest Diagnostics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Quest Diagnostics Incorporated are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Most indicators from Quest Diagnostics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Quest Diagnostics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Quest Diagnostics Incorporated. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. At this time, Quest Diagnostics' Discontinued Operations is fairly stable compared to the past year. Tax Provision is likely to rise to about 266.4 M in 2024, whereas Selling General Administrative is likely to drop slightly above 1.5 B in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 4.2B | 3.4B | 3.1B | 2.7B | Total Revenue | 10.8B | 9.9B | 9.3B | 6.9B |
Quest Diagnostics fundamental ratios Correlations
Click cells to compare fundamentals
Quest Diagnostics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Quest Diagnostics fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 12.8B | 14.0B | 13.6B | 12.8B | 14.0B | 8.5B | |
Short Long Term Debt Total | 5.3B | 4.7B | 4.7B | 4.6B | 5.4B | 3.1B | |
Other Current Liab | 778M | 1.2B | 1.2B | 1.1B | 1.5B | 1.6B | |
Total Current Liabilities | 2.0B | 1.8B | 1.8B | 1.6B | 1.8B | 1.2B | |
Total Stockholder Equity | 5.6B | 6.8B | 6.4B | 5.9B | 6.3B | 3.9B | |
Property Plant And Equipment Net | 2.0B | 2.2B | 2.3B | 2.4B | 2.4B | 2.5B | |
Net Debt | 4.1B | 3.5B | 3.8B | 4.3B | 4.7B | 2.7B | |
Retained Earnings | 8.2B | 9.3B | 7.6B | 8.3B | 8.8B | 9.3B | |
Accounts Payable | 263M | 446M | 357M | 324M | 1.4B | 1.4B | |
Cash | 1.2B | 1.2B | 872M | 315M | 686M | 720.3M | |
Non Current Assets Total | 10.4B | 11.0B | 10.9B | 10.9B | 11.7B | 6.9B | |
Non Currrent Assets Other | 160M | 176M | 163M | 144M | 198M | 176.0M | |
Cash And Short Term Investments | 1.2B | 1.2B | 872M | 315M | 686M | 720.3M | |
Net Receivables | 1.1B | 1.5B | 1.4B | 1.2B | 1.2B | 892.3M | |
Liabilities And Stockholders Equity | 12.8B | 14.0B | 13.6B | 12.8B | 14.0B | 8.5B | |
Non Current Liabilities Total | 5.1B | 5.4B | 5.3B | 5.3B | 5.8B | 3.3B | |
Inventory | 123M | 223M | 208M | 192M | 190M | 104.0M | |
Other Current Assets | 112M | 157M | 223M | 196M | 286M | 227.8M | |
Other Stockholder Equity | (2.5B) | (2.5B) | (1.2B) | (2.4B) | (2.5B) | (2.4B) | |
Total Liab | 7.1B | 7.1B | 7.0B | 6.8B | 7.6B | 4.6B | |
Property Plant And Equipment Gross | 2.0B | 2.2B | 2.3B | 2.4B | 5.8B | 6.1B | |
Total Current Assets | 2.5B | 3.1B | 2.7B | 1.9B | 2.4B | 1.6B | |
Accumulated Other Comprehensive Income | (59M) | (39M) | (21M) | (14M) | 14M | 14.7M | |
Short Term Debt | 949M | 143M | 153M | 155M | 456M | 241.5M | |
Intangible Assets | 1.2B | 1.1B | 1.2B | 1.1B | 1.2B | 968.0M | |
Other Liab | 683M | 847M | 792M | 812M | 933.8M | 472.6M | |
Other Assets | 64M | 1.3B | 163M | 144M | 165.6M | 196.9M | |
Long Term Debt | 4.0B | 4.0B | 4.0B | 4.0B | 4.4B | 3.0B | |
Property Plant Equipment | 1.5B | 1.6B | 2.3B | 2.4B | 2.7B | 2.8B | |
Good Will | 6.6B | 6.9B | 7.1B | 7.2B | 7.7B | 5.7B | |
Treasury Stock | (5.2B) | (5.4B) | (3.5B) | (4.7B) | (4.2B) | (4.4B) | |
Net Tangible Assets | (1.6B) | (700M) | (1.8B) | (1.9B) | (2.1B) | (2.2B) | |
Noncontrolling Interest In Consolidated Entity | 46M | 50M | 39M | 37M | 42.6M | 34.3M | |
Retained Earnings Total Equity | 8.2B | 9.3B | 7.6B | 8.3B | 9.5B | 6.6B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Quest Diagnostics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Quest Diagnostics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Quest Diagnostics Incorporated Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Quest Diagnostics Incorporated Stock:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Quest Diagnostics Incorporated. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Quest Diagnostics information on this page should be used as a complementary analysis to other Quest Diagnostics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Complementary Tools for Quest Stock analysis
When running Quest Diagnostics' price analysis, check to measure Quest Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quest Diagnostics is operating at the current time. Most of Quest Diagnostics' value examination focuses on studying past and present price action to predict the probability of Quest Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quest Diagnostics' price. Additionally, you may evaluate how the addition of Quest Diagnostics to your portfolios can decrease your overall portfolio volatility.
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |
Is Quest Diagnostics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Quest Diagnostics. If investors know Quest will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Quest Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.03) | Dividend Share 2.88 | Earnings Share 7.43 | Revenue Per Share 83.105 | Quarterly Revenue Growth 0.015 |
The market value of Quest Diagnostics is measured differently than its book value, which is the value of Quest that is recorded on the company's balance sheet. Investors also form their own opinion of Quest Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Quest Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Quest Diagnostics' market value can be influenced by many factors that don't directly affect Quest Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Quest Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Quest Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Quest Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.